Cargando…

Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease

We have read with interest the Letter to the Editor by Drs. Zhuang and Zhong, who presented the clinical data of 68 patients with Wilson’s disease (WD) who were admitted to the hospital before and during the coronavirus disease 2019 (COVID-19) pandemic, and appreciated their findings on hepatic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanza, Giuseppe, Godani, Massimiliano, Ferri, Raffaele, Raggi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554399/ https://www.ncbi.nlm.nih.gov/pubmed/34754164 http://dx.doi.org/10.3748/wjg.v27.i39.6733

Ejemplares similares

Challenges with neuropsychiatric Wilson's disease
por: Åberg, Fredrik, et al.
Publicado: (2023)

Wilson′s disease Presenting with Neuropsychiatric Manifestations.
por: Jacob, Rajesh, et al.
Publicado: (2004)

Impact of COVID-19 on the clinical status of patients with Wilson disease
por: Zhuang, Yu-Pei, et al.
Publicado: (2021)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
por: Giacalone, Martina, et al.
Publicado: (2021)

Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins
por: Godani, Massimiliano, et al.
Publicado: (2022)

Severe neuropsychiatric presentation of Wilson's disease
por: Chakor, Rahul T., et al.
Publicado: (2011)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
por: Yasri, Sora, et al.
Publicado: (2022)

Diabetic Striatopathy: Parenchymal Transcranial Sonography as a Supplement to Diagnosis at the Emergency Department
por: Godani, Massimiliano, et al.
Publicado: (2022)

Acute Cerebellar Ataxia and Myoclonus in SARS‐CoV‐2–Related Encephalopathy Responsive to Immunotherapy: A Case Series
por: Grazzini, Matteo, et al.
Publicado: (2022)

Covid-19 treatment-induced neuropsychiatric adverse effects
por: García, C.A. Carrajo, et al.
Publicado: (2020)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

A Review on P300 in Obsessive-Compulsive Disorder
por: Raggi, Alberto, et al.
Publicado: (2021)

Liver histology and histochemistry in Wilson disease
por: Madakshira, Manoj Gopal, et al.
Publicado: (2018)

Wilson disease – Challenge for safe anesthesia!
por: Kaur, Arminder, et al.
Publicado: (2019)

Hypoparathyroidism- An unusual presentation of Wilson's disease
por: Durdana, Shazia
Publicado: (2021)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

Wilson’s disease presenting with unusual radiological features
por: Goyal, Shivraj, et al.
Publicado: (2015)

Adolescent onset Wilson's disease misdiagnosed as psychosis
por: Dudani, Kishore, et al.
Publicado: (2016)

Pregnancy with Wilson's Disease: An Anesthetic Experience with “Ketofol”
por: Kurdi, Madhuri S., et al.
Publicado: (2017)

Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
por: Senra, Hugo
Publicado: (2021)

Impact of COVID-19 pandemic on the worldwide burden of tinnitus
por: Nocini, Riccardo, et al.
Publicado: (2022)

Neuropsychiatric manifestations in patients with long COVID in Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Letter from Dr. Kenneth Wilson
por: Wilson, Kenneth S.
Publicado: (2006)

Anaesthetic management of Mowat–Wilson syndrome
por: Deshmukh, Amit Sudhir, et al.
Publicado: (2016)

Bilateral Optic Neuropathy as the Prominent Manifestation of Wilson’s Disease
por: Yang, Shilin, et al.
Publicado: (2022)

Letter to the Editor: “What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?”
por: Pan, Yuehai, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention
por: Hashimoto, Kenji
Publicado: (2020)

“Sleep in Wilson's disease: Questionnaire based study” – Comments on the article
por: Menon, Vikas, et al.
Publicado: (2013)

MR image mimicking the “eye of the tiger” sign in Wilson’s disease
por: Litwin, T., et al.
Publicado: (2014)

A rare case of Wilson disease associated with intracerebral hemorrhage
por: Singh, Shalendra, et al.
Publicado: (2020)

Unusual Neurological Presentation of Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
por: Pennisi, Manuela, et al.
Publicado: (2017)

Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress
por: Lippi, Giuseppe, et al.
Publicado: (2021)

A Rare Case of Neurofibromatosis Type I with Coexistent Wilson Disease
por: Rai, Tulika, et al.
Publicado: (2018)

Left ventricular clefts – incidental finding or pathologic sign of Wilson’s disease?
por: Zhang, Kun, et al.
Publicado: (2019)

D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021)

Comment on "A rare case of Wilson disease associated with intracerebral hemorrhage"
por: Singh, Shweta A
Publicado: (2021)

Impact of the COVID-19 pandemic on Easter
por: Pavia, Charles S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2p2prd5v1ss6rjb612mk1t09vd